Cardiovascular System in Obesity: Effect of Treatment

NCT00000506 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Heart Diseases
Obesity
Vascular Diseases

Interventions

DRUG: fenfluramine
DRUG: phentermine

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)